RTTNews | Jul 24, 2020 10:13AM EDT

10:12 Friday, July 24, 2020 (RTTNews.com) - Shares of Arbutus Biopharma Corp. (ABUS) gained over 25% on Friday morning after the U.S. Patent and Trademark Office ruled in favor of the company in a patent dispute with Moderna Inc. (MRNA)

ABUS is currently trading at $7.83, up $1.63 or 26.29%, on the Nasdaq.

The decision will help Arbutus make a royalty claim for products developed by Moderna using lipid nanoparticle delivery technology. This technology is currently being used by Moderna to develop a COVID-19 vaccine, known as MRNA-1273.

Moderna had filed the patent case against Arbutus Biopharma in January last year. Moderna argued that Arbutus patent for lipid nanoparticles, the technology used to deliver messenger RNA to a patients' cells, was unpatentable.

Meanwhile, Moderna shares are trading down 7%.

Read the original article on RTTNews ( https://www.rttnews.com/3114161/stock-alert-arbutus-biopharma-up-25-after-winning-patent-dispute-with-moderna.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved